Satiety fills up on $25.3M for obesity treatments
Satiety, maker of a minimally-invasive medical device that reduces obesity, has raised $25.3 million of an anticipated $33 million round of equity and rights, according to a filing with the SEC. The Palo Alto, Calif. company was previously backed by HLM Venture Partners, Morgenthaler Ventures, Pinnacle Ventures, Skyline Ventures, Thomas Fogarty, Three Arch Partners and Venrock. It has raised four rounds of funding to date, not including a $7.5 million bridge loan from its investors… Continue Reading
Spinal Kinetics raises $5.3M to treat degenerative spine diseases
Spinal Kinetics, maker of artificial disks used to treat spine injuries and degenerative diseases, has brought in $5.3 million of an anticipated $9.5 million round of debt, rights and securities, according to a filing with the SEC. The Sunnyvale, Calif. company did not list investors in this round, but has been previously backed by the Ascent Group, BA Venture Partners, De Novo Ventures, HLM Venture Partners, International Life Sciences Fund, Ivy Capital Partners, Lumira Capital… Continue Reading
Satiety secures $7.5M bridge for tummy tuck shortcut
Satiety, maker of a minimally-invasive device that shrinks stomach capacity via the mouth, has landed a $7.5 million bridge loan from its existing investors — a group that includes Skyline Ventures, HLM Venture Partners, Pinnacle Ventures, Morgenthaler Ventures, Three Arch Partners, Venrock and medical inventor Thomas Fogarty, reports VentureWire.
Based in Palo Alto, Calif., the company is still developing its lead product, called the TOGA System, which makes users feel sufficiently full after eating very little…. Continue Reading
Pathway Medical lands generous $40M to treat arterial disease
Pathway Medical Technologies, maker of a non-invasive catheter capable of removing all kinds of artery blockages and build-up, says it just scored $40 million in a fourth round of funding — a pretty high figure for a life science device manufacturer these days. Only about 11 percent of these companies have raised more than $25 million in the last two years. The Kirkland, Wash. company says it will use the money to grow its sales… Continue Reading
Phreesia raises $11.6M to make waiting-room clipboards obsolete
Phreesia, maker of electronic tablets to replace those pesky intake clipboards at doctors’ offices, announced today that it brought in $11.6 million in a round led by BlueCross BlueShield Venture Partners and Sandbox Industries. This brings the New York company’s total capital raised to $25 million — which it plans to use to enlist more doctors to use the product in the U.S. According to Phreesia, thousands already do.
It also says it should be greatly… Continue Reading
Life-science briefing: Wednesday, March 19, 2008
TODAY’S HEADLINES:
Paris-based Stentys takes $18M for “bifurcated” stents (release)
Blood analyzer IntelliDx raises $22M (PDF release)
Cancer-test biotech Calderome changes name to VeraCyte (VentureWire)
Predictive Biosciences names Peter Klemm as CEO (release)
Paris-based Stentys takes $18M for “bifurcated” stents – Stentys, a Paris-based medical device maker, raised $18 million in a second funding round. The company is developing “bifurcated” stents intended to prop open clogged arteries at blood-vessel junctions.
The startup said the funding will allow it to complete clinical trials… Continue Reading
Life-science briefing: Thursday, March 13, 2008
TODAY’S HEADLINES:
Aperio Tech raises $20M for digital pathology (release)
TissueLink changes name, files for $86M IPO (Edgar)
Specialty pharma Cydex files to raise $50M in IPO (Edgar)
Hydra Biosciences takes in $34M for pain drugs (VentureWire)
AVI BioPharma acquires Ercole Biotech for $9M (release)
Juvaris Bio names Grant Pickering as CEO (release)
Aperio Tech raises $20M for digital pathology – Aperio Technologies, a Vista, Calif., developer of systems for digitizing and analyzing medical images, raised $20 million in a third funding round. With… Continue Reading
Life sciences briefing: Thursday, Nov. 29, 2007
Featured companies: Adenosine Therapeutics, Allylix, Caprotec BioAnalytics, Equipois, F-Star, Insightec, MedNets.com, Renal Solutions, Transport Pharmaceuticals, VeriCare Management
UPDATED: Expanded items on Transport Pharmaceuticals, InSightec and VeriCare Management.
Transport Pharma aims for $35M for cold-sore treatment — Framingham, Mass.-based Transport Pharmaceuticals, a dermatology-focused biotech developing a new treatment for cold sores, is looking to raise $35 million in a fifth funding round, VentureWire reports (subscription required). Hillman Co., Quaker BioVentures, Carlyle Group and EGS Healthcare Capital Partners have pledged $15… Continue Reading
Life sciences briefing: Monday, Sept. 17, 2007
Featured companies: Bioptigen, Echo Therapeutics, Forest Laboratories, Intrinsic Therapeutics, Microbia, Phreesia, Sontra Medical, TransMedics, Xanthus Pharmaceuticals
[NOTE: This is a catchup briefing, posted on 9/28/07. I've adjusted the item's timestamp to keep the briefings in chronological order. --D.P.H.]
Patient-info digitizer Phreesia takes in $10.3M — Phreesia, a New York company that claims to offer a “100% free” — but ad-sponsored — digital patient check-in application to doctors, raised $10.3 million in a second funding round. Investors included Polaris Ventures… Continue Reading
Life sciences briefing: Monday, Aug. 6, 2007
(UPDATED at 5:05 p.m. PDT; see below.)
(As part of my ongoing effort to strike the right balance between keeping up with venture-business news and writing more analysis, I’m inaugurating a daily briefing that will collect deal-related news items from the life sciences in one place. I’ll continue updating this post throughout the day as the news dictates. Comments on this or any other feature of this blog are always welcome; sound off below. For more on… Continue Reading
Satiety pulls in $30M for obesity device
Satiety, a Palo Alto, Calif., device maker focused on obesity, raised $30 million in a fourth round of funding. Skyline Ventures led the round, joined by HLM Venture Partners, Pinnacle Ventures, Venrock, Three Arch Partners, Morgenthaler Ventures and Thomas Fogarty.
Satiety is developing a minimally invasive device for stomach-reduction surgery consisting of a stapling tool that can be passed down the throat into the stomach. The company was founded in 2001.